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Abstract 
We examine whether the genetic basis for religious involvement is common to the genetic basis for drug 
use/abuse, helping to explain the inverse relationship between religiosity and drug use. To test this hypothesis, 
we analyzed data on 2,537 young adult siblings participating in Wave III of the National Longitudinal Study of 
Adolescent Health on whom both genetic characteristics and religious participation were collected. 
Religion/spirituality was assessed with four measures: frequency of attendance at religious services and other 
religious youth meetings, frequency of private prayer, self-rated importance of religion and spirituality, and 
self-reported history of a life-changing spiritual experience. Each religious measure was examined individually 
and combined together into a summary scale. Illicit drug use (including prescription drug abuse) was assessed. 
Polymorphisms of the promoter region of the serotonin transporter gene, SLC6A4 (i.e., LL, SL, SS genotypes) 
were determined. Results indicated that (1) all religious measures were inversely related to drug use/abuse, (2) 
the SLC6A4 genotypes SS and SL were less common among those who were more religious, especially among 
non-whites, and (3) SS/SL genotypes were less common among those who used illegal drugs. Despite being less 
likely to have the protective SS/SL genotype, religious adolescents were still less likely to use drugs. (4) There 
was no evidence that the serotonin transporter genotype mediated the relationship between religiosity and illegal 
drug use. These findings suggest that genetic factors play a role in religiosity, especially in non-whites, and that 
both genotype and religiosity independently predict substance abuse. 
Keywords: religion, adolescents, polymorphism, serotonin, addiction, illegal and illicit drugs 
1. Introduction 
1.1 Background 
Much controversy surrounds the role of the serotonin transporter promoter polymorphism, 5-HTTLPR, in 
psychiatric illness. This genetic locus, also called SLC6A4, can have short (S) or long (L) sequences of variable 
number tandem repeats (VNTRs) which encode for less or more of the serotonin transporter protein, respectively. 
In a landmark study, Caspi and colleagues (2003) reported a connection between the S allele of SLC6A4, 
stressful life events, and the development of depression. Since then, SLC6A4 gene locus has been the subject of 
numerous studies, many of which found correlations of the 5-HTTLPR short allele to unfavorable mental health 
outcomes: these include depression (Brown & Harris, 2003), anxiety (Minelli et al., 2011), obsessive compulsive 
disorder (Atmaca et al., 2011), eating disorders (Calati et al., 2011), and substance use (Gerra et al., 2004; Kogan 
et al., 2010; Merenakk et al., 2011). 
1.2 Literature Review 
This literature, like many subfields within psychiatric genomics, is plagued by non-replication and heterogeneity 
(Karg et al., 2011). Two distinct meta-analyses of the topic have recently drawn opposite conclusions on whether 
the connection of SLC6A4 to life stress and depression is supported (Karg et al., 2011; Risch et al., 2009). 
Problems of this kind likely reflect complexity in the relationship of the human genome to behavioral health 
outcomes. Even if measurement error in the outcomes themselves could be eliminated, it would be naive to 
discount additive, mediational, and moderating influences from the environment. This is reflected in the study of 
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how social factors, previously implicated in mental illness, relate to candidate genes in modeling psychiatric 
outcomes. 
One pervasive social influence often linked with mental health is religious involvement (Koenig et al., 2012). 
Although variously measured as attendance at religious services, self-rated importance of spiritual issues, 
frequency of private prayer or meditation, or dependence on religious beliefs in times of stress, religious 
involvement has been found repeatedly to relate inversely with negative outcomes such as depression and all 
types of substance abuse (Dew et al., 2008). These effects have been demonstrated in many cultures, religious 
groups, and across the life cycle (Koenig et al., 2012). Mechanisms underlying these findings have not been fully 
clarified. Many studies show that the salutary effects of religious involvement on depression can be partially 
explained by health behaviors and social support; however, these factors rarely account for all of religion's 
apparent effect (George et al., 2002). Furthermore, the most well documented finding, that substance use is lower 
in religious persons, has not been explored much in terms of mechanism (Edlund et al., 2010). Although it may 
be assumed that proscriptive teachings explain part of this connection, the effect is often observed with regard to 
un-proscribed substances (Michalak et al., 2007). 
How religious involvement as an important environmental factor relates to genotype is not clear. Some studies 
have found religiosity to interact with genetic risk, moderating the inherited tendency to bad outcomes (Beaver et 
al., 2009; Timberlake et al., 2006; Kendler & Myers, 2009). Another question to consider, however, is to what 
extent religiosity is itself genetically determined. Several studies have isolated heritable components (Nilsson et 
al., 2007; Vance et al., 2010; Koenig et al., 2007). In this vein, "effects" of religiosity on health could be partially 
or fully explained as resulting from a common underlying genetic substrate.  
Given the consistent relationship of religiosity to substance abuse and the possible heritable nature of both, 
shared genetics may help to explain the correlation. However, studies of molecular genetics examining 
relationships of religion to substance abuse are few (Beaver et al., 2009; Nilsson et al., 2007). The current study, 
designed to address this gap in the literature, utilizes data from a large cohort of younger adults to explore 
relationships among common candidate genes, use of illicit drugs, and religious beliefs and behaviors. Data on 
common genetic polymorphisms, including those of the SLC6A4 gene, were collected from a subsample of 
approximately 2,500 individuals.  
1.3 Hypotheses 
We hypothesized that: (a) religious involvement will be inversely related to illicit drug use, (b) religious 
involvement will correlate with the presence of polymorphisms of the SLC6A4 gene, (c) drug use will correlate 
with polymorphisms of the SLC6A4 gene, and (d) the SLC6A4 genotype will at least partially explain the 
relationship between religiosity and drug use.  
2. Method 
2.1 Design and Sample Recruitment  
The National Longitudinal Study of Adolescent Health ("Add Health") is a prospective study of a nationally 
representative cohort of Americans from early adolescence through adulthood. Methods of sampling, data 
collection, as well as bio-specimen collection, DNA extraction and analysis have been described elsewhere (Guo 
et al., 2006). The present study utilized de-identified data from a subsample of participants who had blood 
collected for genotyping, consisting of approximately 2537 monozygotic and dizygotic twins, full and half 
siblings, unrelated step siblings, and independent unrelated subjects. Genetic data, as well as information on drug 
use, religiosity, and relevant covariates, were drawn from Wave 3, when subjects were 18-26 years old. 
2.2 Measures and Covariates 
Religiosity was assessed using four measures and a scale that combined these four measures into a single index: 
frequency of attendance at religious services (religious attendance and attendance at youth group functions), 
self-rated importance of religion and spirituality (four questions asking about self-assessed 
religiousness/spirituality and importance of religiousness/spirituality), frequency of private prayer (single 
question), and self-reported history of a life-changing religious experience (single question). These religious 
variables include the most commonly studied constructs in the religion/health literature (Koenig et al., 2012). 
Depressive symptoms and antisocial behaviors (delinquency) were included as psychosocial controls. 
Depression was operationalized as a continuous variable, a composite of responses to 13 items drawn from the 
Center for Epidemiological Studies Depression Scale (CES-D) (Roberts & Vernon, 1983). Delinquency was 
assessed by a summation of responses to 13 items asking about criminal and violent behavior, excluding 
substance use. Drug use was conceptualized as endorsing any use of illicit drugs during the seven years since the 
previous data collection. This measure included prescription drugs taken without a doctor’s permission, as this is 
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a rising trend in substance abuse. Race was analyzed based on a single variable, white vs. non-white (1, 0). This 
more simplistic measure was chosen due to the significant overlap seen in racial and ethnic categories in this 
cohort, where a large number of subjects endorsed multiple categories. Genotype with regard to SLC6A4 was 
coded 1 if either allele included the short coding polymorphism (SS or SL), and 0 if both alleles consisted of the 
long coding polymorphism (LL).  
2.3 Statistical Analyses 
All analyses were performed using SAS Enterprise Guide 5.1 (Cary, NC). Contingency tables were constructed 
and bivariate analyses conducted to assess relationships among all variables. Relationships between religiosity 
measures and SLC6A4 were tested using multivariable models controlled for demographics. For this preliminary 
analysis no attempt was made to account statistically for paired data due to twin or sibling status or the larger 
study’s clustered design.  
Initial analyses evaluated the relationship between religiosity and the serotonin transporter gene. Demographic 
effects initially modeled included age, race, parental education level, and gender; however, gender and parental 
education showed no significant relationship to SLC6A4 genotype and were subsequently dropped. Each of the 
five religious variables was entered into separate models due to the high inter-correlations between measures of 
religiosity. Possible explanatory variables (depression and delinquency scores) were added subsequently. Given 
the known relationship of this genotype to race (Gelernter et al., 1997) and variation in religiosity among races 
(Chatters et al., 2009), a religiosity X race interaction term was added to the model in the final stage.  
Logistic regression models were then constructed predicting use of illicit drugs since the previous data collection 
(1=yes, 0=no). A base model of illicit drug use predicted by race, gender, age, and parental education was 
created. To this model, each of the five religious variables was sequentially added and examined independently. 
SLC6A4 genotype was then added to each model to assess for possible mediation. Potential psychosocial 
mediators (depression and delinquency) were added next. Finally, interaction terms between religiosity and 
SLC6A4 genotype were added to the models, to assess for any interrelationship between these variables.  
3. Results 
3.1 Characteristics of Sample 
There were a total of 2,537 participants who had data on both genotype and religiosity. The sample was nearly 
equally divided by gender (52% female), was predominantly white (72%), and had a mean age of 22 years 
(range 18-26). Average parental education level was 3 years post-secondary school. 
3.2 Bivariate Analyses 
Bivariate statistics indicated significant correlations between race and presence of S allele (SS and S/L) of the 
SLC6A4 genotype, i.e., the SS/SL genotype was more common in whites than non-whites (Table 1). Consistent 
with previous literature, all measures of religious/spiritual involvement were stronger in female subjects and in 
non-whites, and measures of illicit drug use were consistently lower in females and in non-whites. As expected, 
all religious variables correlated significantly and inversely with all measures of substance abuse. Finally, the S 
allele was also correlated with all five religious variables such that subjects with the genotype SS or SL had lower 
levels of religiosity (Table 2). 
3.3 Multivariate Analyses 
Initial multivariable analysis controlled for race, age, gender, and parental education; however, gender and 
parent education were not related to SLC6A4 genotype and were subsequently removed from the model. When 
controlled for race and age, frequency of private prayer and total religiosity score remained significantly and 
inversely correlated with the SS/SL polymorphism of the SLC6A4 gene (Table 3). Due to previous literature 
documenting relationships between religiosity and race, a race X religiosity interaction term was added to each 
model. Both frequency of private prayer and total religiosity score showed significant interactions with race such 
that non-whites with higher religiosity were less likely to have an SS or SL genotype. 
In models controlling for demographics, most religious variables were significantly and inversely related to 
illegal drug use. The only exception was religious experience, which showed a borderline significant bivariable 
correlation but became non-significant when demographics were controlled. Adding SLC6A4 genotype SS/SL 
failed to reduce the effect of any religious variable on illegal drug use. However, the genotype itself was 
significantly and inversely related to illegal drug use, such that the presence of an S allele (SS or SL) was 
protective against drug use (OR=0.82 [95% CI=0.69-0.98]). In models including religious attendance, religious 
importance, prayer, and total religiosity, both the religiosity variable and SLC6A4 genotype maintained 
significance (data not shown). Addition of depression and delinquency to each model revealed that these 
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variables also significantly predicted drug use, although this addition did not alter the effect of the religious 
variables or the genome. No interactions between religiosity variables and genotype were significant in these 
models. Thus, multivariable modeling confirmed religiosity and genotype as independent predictors of illegal 
drug use with no evidence of mediation or moderation. 
4. Discussion 
4.1 Meaning of Findings 
Our original hypotheses were that measures of religiosity/spirituality (R/S) would be inversely related to drug 
use, that R/S would correlate with the presence of polymorphisms of the SLC6A4 gene, that drug use would 
correlate with the presence of the SLC6A4 polymorphism, and that the SLC6A4 genotype would at least 
partially mediate relationships between R/S and illicit drug use. The findings here provided support for the first 
three hypotheses only.  
Presence of one or two copies of the S allele of SCL6A4 gene was associated with lower levels of religious 
involvement (i.e., religious individuals were more likely to have the LL genotype). For some religious measures 
this effect appeared to be explained by race and age (except for frequency of private prayer and total 
religiosity/spirituality scores). Interactions between race and frequency of private prayer or total 
religiosity/spirituality score indicated that the more religious non-white respondents were especially less likely to 
have the LL (vs. the SL/SS) genotype. These relationships are reasonable in light of previous research on race, 
religiosity, depression, and SLC6A4 genotype. Associations between the S allele of the serotonin transporter 
promoter region and depressive illness and anxious personality traits have been known for many years (Risch et 
al., 2009). At the same time, religiosity has been shown to relate inversely to depressive symptoms (Koenig et al., 
1992) and to recovery from depression (Koenig et al., 1998). Religiosity has also been found to be more 
common in African-American populations (Chatters et al., 2009). Therefore it is not surprising to find the 
interaction between religiosity and non-white race in their association with the SLC6A4 genotype.  
We also found that the SLC6A4 genotype was related to use of illicit drugs. Our analyses found that drug use 
was less common among those with the S allele. While most literature about 5-HTTLPR implicates the S allele 
in pathological processes, heterogeneity in studies of substance abuse is not uncommon. The bulk of the 
literature addresses alcoholism. However, there are many studies of SLC6A4 genotype and cigarette smoking, or 
street drugs such as heroin, cocaine, and MDMA. None of these subfields have come to a consensus about how 
this gene relates to use of illicit drugs. With regard to the risk of substance abuse, various studies have found the 
S allele decreases the risk (Laucht et al., 2009; Kweon et al., 2005; Chu et al., 2009), increases the risk (Gerra et 
al., 2004; Kogan et al., 2010; Merenakk et al., 2011; Lichtermann et al., 2000; Matsushita et al., 2001), or is 
unrelated (Gelernter et al., 1997; van der Zwaluw et al., 2011; Kranzler et al., 2002). 
This study supports the hypothesis that the S allele of SLC6A4 decreases the risk of drug use. It may be that the 
increased anxiety associated with having the S allele is protective against drug use because those with this 
polymorphism wish to avoid the associated adverse social consequences. This possibility fits well with recent 
understanding of the S allele as conveying hyper-vigilance, which can have negative or positive consequences 
depending on context (Homberg & Lesch, 2011). 
4.2 Limitations 
Several factors limit the generalizability of these results. Foremost, is that this analysis is preliminary since no 
statistical correction was made for paired data or for the clustered sampling method. Furthermore, we 
acknowledged that many factors that may relate to drug abuse, such as availability, peer deviance, and parental 
monitoring, were not included in the analysis. The strengths of this study, however, are the large sample size and 
detailed measures of religious/spiritual involvement collected. 
4.3 Conclusion 
To our knowledge, this is the first study to examine the relationship between polymorphisms of the serotonin 
transporter gene, religious involvement, and drug use. We found that there was a relationship between the S 
allele, measures of religiosity/spirituality, and illegal drug use. This suggests that religious/spiritual involvement 
is an important factor to consider in future research that examines relationships between genetic factors and drug 
use. 
Perhaps the most novel finding from the study is the relationship between religious/spiritual involvement and 
polymorphisms of the serotonin transporter gene, i.e., the LL genotype. Further study is needed to replicate this 
association. If confirmed, this discovery may help to explain biological mechanisms underlying religion/health 
relationships of all types. Such knowledge could pave the way to novel prevention and treatment strategies. 
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Table 1. Correlation matrix of all study variables 
Gend   Age   Par Ed   Ill Drug   Depress   Deliq   Atten   Import   Pray   Sp Ex   Tot Sp   SCL6A4 
Race        0.01   0.03   0.04*    0.13@     -.09@  -.08@ -.14@      -.20@   -.19@    -.08&    -.20@    0.08@ 
Gender      ---    0.04    0.06^    0.11@  -.10@  0.10@    -.09@    -.09@   -.17@ -.05*    -.13@    0.03 
Age               ---    -.04      -.05*     -.00       0.00  -.02      0.01   0.02  0.01    -.00   0.05* 
Parent education           ---       0.04   -.14@     -.00       0.11@   0.06^    
 
0.04    0.03    0.08&   -.02 
Number of illicit drugs               ---        0.06^   0.12@     -.23@   -.17@   -.14@   -.04     -.22@    -.03 
Depression    ---   0.06^   -.05* -.02    0.01  0.05*    -.02    -.01 
Delinquency      ---       -.04     -.03     0.01    0.02     -.02     -.01 
Religious attendance         ---      0.61@   0.51@   0.39@   0.84@    -.05* 
Importance of religion/spirituality         ---       0.69@   0.44@   0.90@    -.05* 
Prayer           ---   0.36@   0.83@    -.05^ 
Religious experience               ---     0.51@   -.04 
Total religiosity/spirituality              ---      -.06^ 
Race = 1 (white), Gender = 1 (male), SCL6A4=SS/SL (vs. LL) 
* p<0.05, 
^
 p<0.01, 
&
 p<0.001, 
@
 p<0.0001 
Table 2. Uncontrolled associations between SLC6A4 genotype and religious/spirituality measures 
      LL alleles   S/L or SS alleles  t / x
2
 value  p 
Religious attendance  3.09 (3.29)   2.79 (3.06)   2.21    0.03 
(mean, SD)  
 
Importance of religion/  6.25 (3.09)   5.93 (3.04)   2.51    0.01 
spirituality (mean, SD)  
 
Frequency of prayer   3.95 (2.54)   3.67 (2.54)   2.64    <0.01 
(mean, SD) 
 
Religious experience  31%     27%     4.01    0.045 
 
Total religiosity/spirituality 13.62 (7.86)   12.67 (7.65)   2.91    <0.005 
(mean, SD) 
Table 3. Correlations of religiosity to SLC6A4 (SS/SL) controlled for demographics, and significance of the race 
x religiosity interaction term in each model 
          Controlled for      Race x Religiosity 
          Race & Age      Interaction  
                (β)         (β)      
Religious attendance            0.02 
t
       0.01  
Importance of religion/spirituality          0.03
 t
       0.03 
t
  
Prayer               0.04 *       0.05**  
Religious experience           -0.09
 t
         -0.03  
Total religiosity score         0.01 *       0.01 *  
t
 0.05<p<0.10, * p<0.05, ** p<0.01 
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